Yale, Biohaven Win $4M In Biotech Trade Secret Trial
A Delaware federal jury has awarded Yale University and Biohaven Therapeutics $4 million after finding that venture capital firm RA Capital Management GP breached a confidentiality agreement and, along with co-defendant...To view the full article, register now.
Already a subscriber? Click here to view full article